Rep. Lisa C. McClain Sells Exelon Corporation (NASDAQ:EXC) Stock

Representative Lisa C. McClain (R-Michigan) recently sold shares of Exelon Corporation (NASDAQ:EXC). In a filing disclosed on November 21st, the Representative disclosed that they had sold between $1,001 and $15,000 in Exelon stock on October 30th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Coherent (NYSE:COHR) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Clorox (NYSE:CLX) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Northern Trust (NASDAQ:NTRS) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Honda Motor (NYSE:HMC) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Home BancShares (NYSE:HOMB) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Five Below (NASDAQ:FIVE) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Pure Storage (NYSE:PSTG) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of BHP Group (NYSE:BHP) on 10/31/2025.

Exelon Stock Performance

NASDAQ EXC traded up $0.79 on Friday, reaching $47.36. 3,792,758 shares of the company’s stock traded hands, compared to its average volume of 7,158,820. Exelon Corporation has a fifty-two week low of $35.94 and a fifty-two week high of $48.51. The company has a debt-to-equity ratio of 1.66, a quick ratio of 0.85 and a current ratio of 0.95. The firm has a market cap of $47.85 billion, a price-to-earnings ratio of 18.01, a P/E/G ratio of 2.93 and a beta of 0.44. The stock has a 50 day moving average price of $46.15 and a 200-day moving average price of $44.50.

Exelon (NASDAQ:EXC) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.17. Exelon had a return on equity of 9.85% and a net margin of 11.16%.The company had revenue of $6.71 billion during the quarter, compared to analysts’ expectations of $6.40 billion. Exelon has set its FY 2025 guidance at 2.640-2.740 EPS. Equities research analysts predict that Exelon Corporation will post 2.64 EPS for the current fiscal year.

Exelon Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 15th. Investors of record on Monday, November 10th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 3.4%. The ex-dividend date of this dividend is Monday, November 10th. Exelon’s dividend payout ratio (DPR) is 57.35%.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Wells Fargo & Company raised shares of Exelon to a “strong-buy” rating in a report on Tuesday, October 28th. Barclays raised their target price on Exelon from $48.00 to $52.00 and gave the company an “overweight” rating in a research report on Tuesday, October 14th. Morgan Stanley reaffirmed an “underperform” rating and issued a $52.00 price target on shares of Exelon in a report on Thursday, November 20th. KeyCorp increased their price target on Exelon from $37.00 to $42.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 15th. Finally, Evercore ISI initiated coverage on Exelon in a research report on Monday, October 6th. They issued an “outperform” rating and a $57.00 price objective for the company. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $50.45.

Hedge Funds Weigh In On Exelon

Several hedge funds and other institutional investors have recently made changes to their positions in the company. CIBC Private Wealth Group LLC raised its stake in Exelon by 28.2% in the 3rd quarter. CIBC Private Wealth Group LLC now owns 19,846 shares of the company’s stock valued at $893,000 after purchasing an additional 4,363 shares during the last quarter. CIBC Bancorp USA Inc. acquired a new stake in shares of Exelon in the third quarter valued at about $7,935,000. Asset Dedication LLC lifted its stake in shares of Exelon by 56.3% in the third quarter. Asset Dedication LLC now owns 1,216 shares of the company’s stock worth $55,000 after buying an additional 438 shares in the last quarter. Coldstream Capital Management Inc. boosted its position in Exelon by 23.2% during the third quarter. Coldstream Capital Management Inc. now owns 37,612 shares of the company’s stock worth $1,693,000 after acquiring an additional 7,077 shares during the last quarter. Finally, Danske Bank A S purchased a new stake in Exelon during the 3rd quarter valued at about $51,779,000. Hedge funds and other institutional investors own 80.92% of the company’s stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Exelon

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.